An observational study in Otitis Media, Otitis Media With Effusion and Pneumococcal Infections, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer. Completed at 35 sites in France. Open to participants aged 6 Months to 24 Months. Per ClinicalTrials.gov, last updated 2010-06-29.
Sponsored by Wyeth is now a wholly owned subsidiary of Pfizer · Observational
The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's enrollment of 3,293 is above the median of 203 across 688 observational studies indexed under Pneumonia.
Browse Pneumonia studies →Wyeth is now a wholly owned subsidiary of Pfizer is the lead sponsor of 472 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Screening, Cross-Sectional, Defined Population, Prospective Study
Other inclusion applies.
Exclusion Criteria:
This study is completed, as verified in Jun 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wyeth is now a wholly owned subsidiary of Pfizer